2022
DOI: 10.1007/s11095-022-03262-6
|View full text |Cite
|
Sign up to set email alerts
|

Osmolality of Excipients for Parenteral Formulation Measured by Freezing Point Depression and Vapor Pressure – A Comparative Analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 42 publications
0
2
0
Order By: Relevance
“…Serum osmolality is very precisely regulated by altering the amount of sodium and water excreted from the body and is maintained in a narrow range 275 to 295 mOsm/kg H 2 O [9] . Osmolality can be measured (O meas ) using the phenomenon of changing the properties of a solvent, like freezing point, boiling point or vapour pressure, due to osmotically active substances dissolved [10] [11] . In many laboratories it is not possible to measure osmolality directly, therefore serum osmolarity is calculated (O cal ) by different formulas, usually taking into account the concentration of osmotically active substances present in the plasma, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…Serum osmolality is very precisely regulated by altering the amount of sodium and water excreted from the body and is maintained in a narrow range 275 to 295 mOsm/kg H 2 O [9] . Osmolality can be measured (O meas ) using the phenomenon of changing the properties of a solvent, like freezing point, boiling point or vapour pressure, due to osmotically active substances dissolved [10] [11] . In many laboratories it is not possible to measure osmolality directly, therefore serum osmolarity is calculated (O cal ) by different formulas, usually taking into account the concentration of osmotically active substances present in the plasma, i.e.…”
Section: Introductionmentioning
confidence: 99%
“…The preparation of LAIs is comprised of a wide range of different formulation techniques where the main formulation groups consist of in situ gels, implants, oil-based formulations, polymeric microspheres, and aqueous suspensions of crystalline drug particle in micron to submicron range [1,7]. Several LAIs based on these technologies have been regulatory approved and are used for the treatment of different diseases such as schizophrenia (e.g., Risperdal Consta® and Invega Sustenna®) or human immunodeficiency virus (HIV) (e.g., Vocabria®) [1,5,6,8,9].…”
Section: Introductionmentioning
confidence: 99%